Injuv® is an easily absorbed, low molecular weight hyaluronic acid. Size exclusion high-performance liquid chromatography has verified that the low molecular weight hyaluronic acids contained in Injuv® are estimated to be between 1,500 and 5,000 Daltons — less than one percent of their original size. As a result, Injuv® is absorbed easily through the intestinal tract.
Injuv® is derived from rooster combs, which have been safely used as a source of hyaluronic acid for more than 20 years, in the form of an injectable treatment for osteoarthritis of the knee. Not only does this type of hyaluronic acid have a natural affinity for human tissues, it has been clinically shown not to cause an allergic response.
Delivered to the Skin
Of course, it doesn’t matter if something is absorbed if it’s not delivered where it’s needed in the body. The absorption and delivery of Injuv® has been demonstrated using a well-established animal model to measure wound healing capacity. The physiological activity of Injuv® — illustrated by the fact that rats treated with oral Injuv® experienced significantly improved wound healing compared to those given placebo — is a reliable indicator that Injuv® is absorbed and delivered to the target tissue: the skin.
The process used to produce Injuv® hyaluronic acid is so unique, it’s been awarded a patent in Japan (#2971860).